Diabetes Research
To learn more about diabetes and clinical trials being carried out in this area, visit our Diabetes Research page.
This study is being done to test the safety and efficacy of the study drug LY3852710 for the treatment of diabetic peripheral neuropathic pain.
Participants must have daily pain for at least 12 weeks
Participants must be willing to maintain any non-drug pain relieving therapies (for example, physical therapy) and not start any new non-drug pain-relieving therapies during the study
Participants must be willing to stop all pain medications for diabetic nerve pain, except for rescue medication allowed in the study
Participants must have type 1 or type 2 diabetes and stable glycemic control
Participants must not have surgery planned during the study for any reason
Participants must not have an intolerance to acetaminophen or paracetamol
Participants must not have a history of alcohol or drug disorder within 2 years
Participants must not have a current drug-induced neuropathy, for example, due to some types of chemotherapy, or other types of peripheral neuropathy
Have a seizure disorder or history of seizure
To learn more about diabetes and clinical trials being carried out in this area, visit our Diabetes Research page.
For the past 20 years, Lilly has worked to develop treatments for people living with chronic or regular pain. Click the below button to learn more about pain research and clinical trials.
Learn MoreA clinical trial is a scientific study. It helps us learn if a new medicine or treatment works and how it works. Clinical trials can also be called clinical research studies. Learn more about clinical research studies and what to expect when taking part in a clinical trial.